Valbiotis Stock
Price
Target price
€3.88
€3.88
1.310%
0.05
1.310%
-
24.04.24 / Frankfurt
WKN: A2DS5F / Name: Valbiotis / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Valbiotis Stock
Valbiotis gained 1.310% today.
So far the community has only identified positive things for Valbiotis stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Valbiotis in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Valbiotis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Valbiotis | 1.310% | - | - | - | - | - | - |
| Cerenis Therapeutics Holding S.A. | -1.020% | -4.942% | 13.410% | -45.500% | -20.373% | 2.188% | 211.429% |
| Sensorion SA | -3.540% | 0.593% | -15.776% | 123.026% | 69.500% | -69.528% | - |
| Genoway S.A. Inh. | 0.790% | -1.305% | -7.579% | 0.532% | -14.286% | 13.855% | 112.360% |
News
Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May
Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May
Valbiotis presents its 2024 financial communication calendar
Valbiotis presents its 2024 financial communication calendar
Valbiotis sets out its commercial and clinical roadmap for 2024
Valbiotis sets out its commercial and clinical roadmap for 2024